[Clinical and immunological studies on severe adult measles].
Shinzato
Takashi
T
D000328:Adult; D000367:Age Factors; D015703:Antigens, CD; D017209:Apoptosis; D003428:Cross Infection / Q000517:prevention & control; D006023:Glycoproteins; D006801:Humans; D007136:Immunoglobulins; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D007371:Interferon-gamma; D015847:Interleukin-4; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology / Q000821:virology; D008457:Measles / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D008458:Measles Vaccine; D008459:Measles virus / Q000472:pathogenicity / Q000502:physiology; D010356:Patient Isolation; D011956:Receptors, Cell Surface; D011991:Receptors, Virus; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D014779:Virus Replication
D015703:Antigens, CD; D006023:Glycoproteins; D007136:Immunoglobulins; D008458:Measles Vaccine; D011956:Receptors, Cell Surface; D011991:Receptors, Virus; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D015847:Interleukin-4; D007371:Interferon-gamma